Generics
The bulk of Mylan’s product portfolio, which tops 900 individual products, includes high quality, more affordable generic
medications sold throughout the world. Generic drugs are tried-and-true versions of brand-name pharmaceuticals and have been
used by millions for decades. While the active pharmaceutical ingredient in a generic drug and its proprietary counterpart
are chemically identical, generic drugs typically cost far less than brand-name drugs because their producers don’t have
to invent them from scratch.
The generics industry continues to grow as an aging population, a strong desire to reduce health care outlays, and an
increasing reliance on generics continue to fuel demand. Mylan is armed and ready to continue to seamlessly and efficiently
deliver high quality products at competitive prices that offer solutions to health care demands across the globe.
Mylan innovates every day to be among the first to bring new generics to market. Introducing groundbreaking delivery
technologies, and difficult-to-manufacture and difficult-to-formulate pharmaceuticals are just a few of the ways Mylan
demonstrates that it is anything but generic.